{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2006"],"condition":["Lung Cancer","Colorectal Cancer","Fatigue","Depression","Depressive Disorder","Liver Cancer","Pancreatic Cancer","Gallbladder Cancer","Liver Neoplasms","Extrahepatic Bile Duct Cancer","Lung Neoplasms","Esophageal Neoplasms","Gallbladder Neoplasms","Bile Duct Neoplasms","Gastric Cancer","Esophageal Cancer","Pancreatic Neoplasms","Stomach Neoplasms","Cholangiocarcinoma"],"disease":["Lung Cancer","Colorectal Cancer","Fatigue","Depression","Depressive Disorder","Liver Cancer","Pancreatic Cancer","Gallbladder Cancer","Liver Neoplasms","Extrahepatic Bile Duct Cancer","Lung Neoplasms","Esophageal Neoplasms","Gallbladder Neoplasms","Bile Duct Neoplasms","Gastric Cancer","Esophageal Cancer","Pancreatic Neoplasms","Stomach Neoplasms","Cholangiocarcinoma"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2033517"],"location":["United States"],"study_start_month":["3"],"keyword":["Advanced adult primary liver cancer","Stage IVB rectal cancer","Stage IV pancreatic cancer","Unresectable extrahepatic bile duct cancer","Escitalopram","Stage IVA rectal cancer","Stage IV esophageal cancer","Citalopram","Stage IV non-small cell lung cancer","Dexetimide","Psychosocial effects of cancer and its treatment","Stage IVA colon cancer","Stage III pancreatic cancer","Stage IVB colon cancer","Extensive stage small cell lung cancer","Stage IIIB non-small cell lung cancer","Unresectable gallbladder cancer","Stage IV gastric cancer"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer","description":"RATIONALE: Escitalopram may help improve depression and quality of life in patients with advanced lung or gastrointestinal cancer. It is not yet known whether escitalopram is more effective than a placebo in treating depression in patients with advanced lung or gastrointestinal cancer.\nPURPOSE: This randomized clinical trial is studying the side effects of escitalopram and to see how well it works compared to a placebo in treating depression in patients with advanced lung or gastrointestinal cancer.","dates":{"creation":"2006-03-15"},"accession":"2033517","cross_references":{"ClinicalTrials___gov":["NCT00387348"]}}